The European Commission has granted authorization to GSK's HIV-focused division, ViiV Healthcare, for its cabotegravir in both long-acting injectable and tablet forms.
The GlaxoSmithKline logo is seen in this illustration, Aug. 10, 2022.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Poland proposes ban on Russian diamonds, LPG in new sanctions packageThe Polish proposal will now be considered by the European Commission.
Read more »
European shares slip with central banks in focus; Nordic Semiconductor slumps By ReutersEuropean shares slip with central banks in focus; Nordic Semiconductor slumps
Read more »
European shares slip as industrials drag; focus on c.banks meetings By ReutersEuropean shares slip as industrials drag; focus on c.banks meetings
Read more »
HIV-positive Florida track coach accused of sexually battering a teenage boyThe Polk County Sheriff's Office arrested a track coach who allegedly attempted to engage in sexual activity with a teenage student without disclosing he was HIV positive.
Read more »
SF AIDS Foundation, Uber providing free rides for HIV/AIDS patients heading to doctor's officeOn National HIV/AIDS and Aging Awareness Day, reporter Shawn Chitnis highlights a community program is offering free Uber rides for people needing to get to clinics and health care providers.
Read more »
Dr. Fauci and Colleagues Await AIDS Relief Reauthorization by CongressContinuing PEPFAR will ensure millions of people access to prevention, care, and treatment for HIV/AIDS.
Read more »